Antineoplastic Agents

Antineoplastic Agents Companies (9)

Antineoplastic Agents Products (16)

  • Product EVER Pharma Product List

    Our products include: Atosiban Cabazitaxel Cebrium(R) Cerebrolysin(R) Dacepton(R) Dexmedetomidine Docetaxel Fulvestrant MemoProve(R) Oxytocin Paclitaxel Pemetrexed Tachyben(R) Terlipressin
  • Product Lenvatinib Mesilate Capsules

    This product is suitable for patients with unresectable hepatocellular carcinoma who have not previously received systemic therapy.The pivotal study of lenvatinib mesylate excluded patients with HCC amenable to local therapy, for whom no study data are available. 
  • Product Amilix/Bromadene

    Azacitidine Drug of choice in adult patients who are not considered candidates for hematopoietic stem cell transplantation and who suffer from: myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia. Each vial contains azacitidine 100 mg as a sterile lyophilized powder for ...
  • Product APIs

    • Paclitaxel (Package : Up to 500g Per request) • Pemetrexed (Package : Up to 1kg Per request) • Bortezomib (Package : Up to 40g Per request)
  • Product Erythropoietin for Injection (EPO)

    1000iu, 2000iu, 3000iu, 4000iu, 10000iu
  • Product Enlength

    As a cornerstone drug for the treatment of multiple myeloma, Bortezomib is used throughout the induction, consolidation and maintenance therapies for myeloma. In 2020, Bortezomib was recommended as a first-line drug for the full management of multiple myeloma in the Guidelines for Diagnosis and Treatm...
  • Product Neutromax 30 M I.U./ 48 M I.U.

    Filgrastim is a recombinant methionyl human granulocyte colony stimulating factor (r-Met-Hu-GCSF), produced by bacterial fermentation. Filgrastim is used to treat neutropenia, a side effect of chemotherapy, which makes patients more susceptible to bacterial infections.
    Biosidus Filgrastim product is av...
  • Product CDMO

    • Cytotoxic Injection (Liquid , Lyophilized) • ONCOLOGY  • CYTOTOXIC API • EU GMP  • JGMP (Japan) • KGMP (Korea) • PIC/S
  • Product Venetoclax

    Commercial US DMF inprogress
  • Product INJECTIONS

    Albumin bound Paclitaxel Inj Azacitadine Inj Bendamustin Inj Bortezomib Inj Busulfan Inj Carboplatin Inj Carfilzomib Inj Carmustin Inj Cisplatin Inj Cytrabine Inj Dacarbazine Inj Dactinomycin Inj Degrarelix Inj Doceteaxel Inj Doxorubicin Inj Epirubicin Inj Eribulin Inj Etoposide Inj Fludarabine Inj Fosapre...
  • Product products

    Tablets 1 Zefinib Gefitinib 250mg 1 x 10 2 Capetaz Capecetabine 500mg 1 x 10 3 Anastroz Anastrozole 1mg 1 x 10 4 Zutam Tamoxifen 20mg 1 x 10 5 Zuvitrex Methotrexate 2.5mg 1 x 10 6 Zuvitrex Methotrexate 7.5mg 1 x 10 7 Erlonon Erlotinib 100mg 1 x 10 8 Erlonon Erlotinib 150mg 1 x 10 9 Zuvitroz Letrozole ...
  • Product Pemecine - Pemetrexed

    Composition: Pemetrexed 100 mg & 500 mg

    Indication: The treatment of malignant pleural mesothelioma & non-small cell lung cancer

    Packed in : Dry vial 100 mg & 500 mg

  • Product Tezobell - Bortezomib

    Composition: Bortezomib 3.5 mg

    Indication: 
    The treatment of multiple myeloma patients who have received at least 1 prior therapy and have demonstrated disease progression on the last therapy. 

    Packed in : Dry vial 3.5 mg
  • Product Chemotherapy

    Cytopharma is the first pharmaceutical company in Africa & Middle East region entirely specialized in the development, manufacturing and marketing of high quality and affordable generic cytotoxic drugs. Established in Tunisia since 2011, Cytopharma purpose is to provide high quality and affordable...

Upcoming Events

  • CPHI Middle East 2024

    Riyadh Front Exhibition & Convention Center Riyadh, Saudi Arabia
    10 Dec 2024 - 12 Dec 2024
  • Pharmapack Europe 2025

    Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
    22 Jan 2025 - 23 Jan 2025
  • CPHI Japan 2025

    East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
    09 Apr 2025 – 11 Apr 2025

Pharmaceutical Industry Webinars